| [1] |
N, Paterson DL. Mycobacterium tuberculosis infection in solid−organ transplant recipients: Impact and implications for management[J]. Clin Infect Dis, 1998,27（5）:1266-1277.
|
| [2] |
JM, Torre−Cisneros J, Fortún J, et al. Tuberculosis insolid−organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients （GESITRA） of the Spanish Society of Infectious Diseases and Clinical Microbiology[J]. Clin Infect Dis, 2009,48（9）:1276-1284.
|
| [3] |
P, Rodríguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants[J]. Clin Infect Dis, 2005,40（4）:581-587.
|
| [4] |
N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area[J]. Transplantation, 2002,74（10）:1381-1386.
|
| [5] |
A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients[J]. Am J Transplant, 2009,9（Suppl 4）:S57-S62.
|
| [6] |
J, Eghtesad B, Stock DJ, et al. Guidelines for the prevention and management of infectious complications of solid organ transplantation[J]. Am J Transplant, 2004,4（Suppl 10）:37-41.
|
| [7] |
RL, Ferrer X, Latrach C, et al. The influence of Calmette−Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults[J]. Am Rev Respir Dis, 1990,142（1）:24-28.
|
| [8] |
RE, Schein MF, Bass JB Jr, et al. The tuberculin skin test[J]. Clin Infect Dis, 1993,17（6）:968-975.
|
| [9] |
L, Turner MO, Elwood RK, et al. A meta−analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements[J]. Thorax, 2002,57（9）:804-809.
|
| [10] |
D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion[J]. Am J Respir Crit Care Med, 1999,159（1）:15-21.
|
| [11] |
M, Zwerling A, Menzies D. Systematic review: T−cell−baseda assays for the diagnosis of latent tuberculosis infection: An update[J]. Ann Intern Med, 2008,149（3）:177-184.
|
| [12] |
M, Riley LW, Colford JM Jr. Interferon−gamma assays in the immunodiagnosis of tuberculosis: A systematic review[J]. Lancet Infect Dis, 2004,4（12）:761-776.
|
| [13] |
D, Pai M, Comstock G. Meta−analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research[J]. Ann Intern Med, 2007,146（5）:340-354.
|
| [14] |
Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000[J]. Thorax, 2000,55（11）:887-901.
|
| [15] |
P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews [J]. BMC Med Res Methodol, 2003,3:25.
|
| [16] |
SY, Jung GS, Kim SK,et al. Comparison of the tuberculin skin test and interferon−c release assay for the diagnosis of latent tuberculosis infection before kidney transplantation[J]. Infection, 2013,41（1）:103-110.
|
| [17] |
SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T cell−based assay for latent tuberculosis infection in kidney transplant candidates before transplantation[J]. Transpl Infect Dis, 2010,12（2）:113-119.
|
| [18] |
L, Losi M, D′Amico R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients[J]. Chest, 2009,136（1）:198-204.
|
| [19] |
O, Humar A, Preiksaitis J, et al. Comparison of quantiferon−TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation[J]. Am J Transplant, 2007,7（12）:2797-2801.
|
| [20] |
M, Dioury Y, Beckebaum S, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation[J]. Hum Immunol, 2009,70（1）:24-28.
|
| [21] |
S, Muñoz L, Moure R, et al. Comparison of the 2−step tuberculin skin test and the quantiFERON−TB Gold In−Tube Test for the screening of tuberculosis infection before liver transplantation[J]. Liver Transpl, 2011,17（10）:1205-1211.
|
| [22] |
JZ, Cattamanchi A, Vittinghoff E, et al. Evaluation of quantitative IFN−gamma response for risk stratification of active tuberculosis suspects [J]. Am J Respir Crit Care Med, 2010,181（1）:87-93.
|
| [23] |
E, Janssens JP, Roux−Lombard P, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: Comparison of an interferon−gamma release assay vs. tuberculin skin test[J]. Br J Dermatol, 2009,161（4）:797-800.
|
| [24] |
N, Fu YT, Qian H, et al. Performance of interferon−gamma release assays in patients with inflammatory bowel disease: A systematic review and meta−analysis[J]. Inflamm Bowel Dis, 2012,18（11）:2034-2042.
|
| [25] |
JZ, Everett CK, Steingart KR, et al. Interferon−γ release assays for active pulmonary tuberculosis diagnosis in adults in low− and middle−income countries: Systematic review and meta−analysis[J]. J Infect Dis, 2011,204（Suppl 4）: S1120-S1129.
|
| [26] |
V, Perry S, Parsonnet J, et al. Clinical application and limitations of interferon−gamma release assays for the diagnosis of latent tuberculosis infection[J]. Clin Infect Dis, 2011,52（8）:1031-1037.
|
| [27] |
R, Cattamanchi A, Steingart KR, et al. Interferon−γ release assays for diagnosis of latent tuberculosis infection: Evidence in immune−mediated inflammatory disorders[J]. Curr Opin Rheumatol, 2011,23（4）:377-384.
|
| [28] |
V, Pottier G, Bonkain F, et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays[J]. PLoS One, 2012,7（8）:e43285.
|
下载: